{"disease":{"id":"low-to-intermediate-1-risk-myelodysplastic-syndromes-mds-with-transfusion-dependent-anemia-requiring-4-or-more-red-blood-cell-units-over-8-weeks-who-have-not-responded-to-or-have-lost-response-to-or-are-ineligible-for-erythropoiesis-stimulating-agents-esa.md","name":"low to intermediate 1 risk myelodysplastic syndromes mds with transfusion dependent anemia requiring 4 or more red blood cell units over 8 weeks who have not responded to or have lost response to or are ineligible for erythropoiesis stimulating agents esa.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}